Shares are at $1.12 The company recently announced plans to present at an upcoming conference. The stock has significant pre-market volume with more than 9.751 million shares traded as of this post.
Alaunos Therapeutics to Present at the Jefferies Healthcare Conference
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research & Development will present at the upcoming Jefferies Healthcare Conference being held on June 8-10, 2022, in New York, NY.